Melinda L Aquino, MD
Vascular Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 2 carriers
- Offices
- 3
- Since medical school
- 28 years
- Indiana University School of Medicine, 1998
Offices
3 locations · West Coast Kidney · San Mateo Dialysis Associates
Looking this up.
Hospitals listed: Ahmc Seton Medical Center · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
4 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aquino’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
4 of 4 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A94731 · Current
Licensed to practise in California · since 2006 · expires 2027-12-31 · Indiana University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Surgery - Surgery
- American Board of Surgery - Vascular Surgery
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$196,404
Medicare paid this office $196,404 for 250 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 23 | $30,126 | $1,076 |
| Short return visit (20+ min) | 159 | $26,820 | $83 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 85 | $17,817 | $188 |
| New patient visit (30+ min) | 99 | $9,746 | $98 |
| Injection of chemical agent into multiple incompetent veins of leg | 21 | $9,727 | $263 |
See all 13 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 23 | $30,126 | $1,076 |
| Short return visit (20+ min) | 159 | $26,820 | $83 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 85 | $17,817 | $188 |
| New patient visit (30+ min) | 99 | $9,746 | $98 |
| Injection of chemical agent into multiple incompetent veins of leg | 21 | $9,727 | $263 |
| Ultrasound of leg arteries or artery grafts | 22 | $6,251 | $250 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 39 | $5,848 | $124 |
| Ultrasound of hemodialysis access | 24 | $4,765 | $132 |
| Ultrasound of both sides of head and neck blood flow | 25 | $4,232 | $169 |
| Return visit (30+ min) | 30 | $4,163 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,526 | $141 |
| New patient visit (45+ min) | 15 | $1,720 | $115 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $260 | $10 |
Procedures Medicare counted
| Leg revascularization (restoring blood flow) | 36 | More than 87% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Varicose vein removal | 74 | More than 80% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of chemical agent into multiple incompetent veins of leg | 50 | 17 | 25 | 38 | 24 | 37 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 30 | – | 34 | 42 | 24 | 28 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 18 | 26 | 14 | 12 | 15 | – |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | – | 12 | 18 | – | – | – |
| Balloon dilation of artery of leg | – | 14 | 14 | – | – | – |
| Creation of artery-vein connection using vein graft for hemodialysis | – | 14 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
250 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 19% · Women 60% · Also on Medicaid 48% · Health risk score 2.92. Above the middle of the specialty; the typical vascular surgery clinician is at 2.33.
Conditions among them: High blood pressure 75% · Diabetes 47% · Chronic kidney disease 44% · Coronary heart disease 34% · Heart failure 29% · Atrial fibrillation 23% · Stroke 21% · COPD 18% · Depression 18% · Dementia 14% · Cancer 10%.
The office billed $817,842, Medicare allowed $254,671 and paid $196,404; for 999 services of 82 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 250 | 999 | 75 | 2.92 | $817,842 | $196,404 |
| 2023 | 242 | 1,029 | 75 | 3.17 | $839,990 | $183,002 |
| 2022 | 248 | 1,130 | 74 | 3.24 | $986,745 | $220,383 |
| 2021 | 227 | 1,236 | 74 | 3.43 | $929,947 | $239,293 |
| 2020 | 235 | 1,195 | 74 | 4.07 | $946,148 | $260,698 |
| 2019 | 203 | 909 | 74 | 2.90 | $837,004 | $193,238 |
| 2018 | 208 | 1,274 | 75 | 2.60 | $643,836 | $187,050 |
| 2017 | 197 | 851 | 74 | 2.91 | $503,182 | $165,337 |
| 2016 | 190 | 802 | 73 | 2.90 | $549,726 | $157,122 |
| 2015 | 283 | 681 | 77 | 2.35 | $394,455 | $106,008 |
| 2014 | 364 | 740 | 78 | 2.32 | $341,947 | $101,594 |
| 2013 | 338 | 754 | 78 | 2.37 | $364,642 | $110,878 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 16 | $26,771 | $1,115 |
| Short return visit (20+ min) | 136 | $19,925 | $79 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 73 | $14,719 | $189 |
| Ultrasound of hemodialysis access | 45 | $10,533 | $125 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 15 | $8,162 | $544 |
| Return visit (30+ min) | 59 | $7,746 | $105 |
| New patient visit (45+ min) | 57 | $7,732 | $136 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 36 | $6,436 | $124 |
| Injection of chemical agent into multiple incompetent veins of leg | 18 | $6,130 | $255 |
| Ultrasound of leg arteries or artery grafts | 20 | $5,046 | $240 |
| Ultrasound of both sides of head and neck blood flow | 22 | $4,114 | $187 |
| New patient visit (30+ min) | 39 | $4,094 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,306 | $144 |
| Ultrasound study of arm and leg arteries | 13 | $1,805 | $82 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $349 | $11 |
| Ultrasonic guidance for blood vessel access | 15 | $228 | $12 |
2022: 14 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 30 | $49,568 | $1,180 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 98 | $21,072 | $195 |
| Return visit (30+ min) | 111 | $17,598 | $112 |
| New patient visit (45+ min) | 111 | $15,654 | $141 |
| Short return visit (20+ min) | 124 | $15,536 | $81 |
| Injection of chemical agent into multiple incompetent veins of leg | 20 | $9,812 | $258 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 50 | $9,319 | $128 |
| Ultrasound of leg arteries or artery grafts | 33 | $8,247 | $243 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 11 | $6,385 | $532 |
| Ultrasound of hemodialysis access | 28 | $5,391 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $3,559 | $178 |
| Ultrasound of both sides of head and neck blood flow | 16 | $3,224 | $190 |
| Ultrasonic guidance for blood vessel access | 17 | $280 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $196 | $11 |
2021: 18 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 25 | $45,160 | $1,328 |
| Short return visit (20+ min) | 129 | $24,413 | $81 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 78 | $17,985 | $200 |
| Ultrasound of leg arteries or artery grafts | 41 | $12,868 | $263 |
| Return visit (30+ min) | 77 | $12,391 | $120 |
| Ultrasound of hemodialysis access | 43 | $11,594 | $123 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 12 | $7,794 | $557 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 42 | $7,194 | $128 |
| New patient visit (45+ min) | 46 | $6,469 | $141 |
| Injection of chemical agent into multiple incompetent veins of leg | 16 | $6,236 | $249 |
| Ultrasound of both sides of head and neck blood flow | 29 | $6,160 | $192 |
| New patient visit (30+ min) | 60 | $5,731 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,359 | $156 |
| Balloon dilation of artery of leg | 12 | $3,747 | $268 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 13 | $2,718 | $151 |
| Ultrasound study of arm and leg arteries | 12 | $981 | $82 |
| Ultrasonic guidance for blood vessel access | 28 | $431 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $369 | $11 |
2020: 18 services
| Short return visit (20+ min) | 139 | $19,714 | $68 |
| Ultrasound of hemodialysis access | 52 | $17,953 | $137 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 25 | $14,594 | $561 |
| Ultrasound of leg arteries or artery grafts | 51 | $14,114 | $266 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 53 | $10,494 | $194 |
| Creation of artery-vein connection using vein graft for hemodialysis | 12 | $9,145 | $653 |
| New patient visit (45+ min) | 64 | $8,921 | $139 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,832 | $170 |
| Ultrasound of both sides of head and neck blood flow | 29 | $5,303 | $183 |
| Return visit (30+ min) | 41 | $4,893 | $98 |
| Injection of chemical agent into multiple incompetent veins of leg | 11 | $4,357 | $256 |
| Balloon dilation of artery of leg | 13 | $4,205 | $300 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 29 | $3,967 | $124 |
| New patient visit (30+ min) | 37 | $3,711 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $2,166 | $94 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 11 | $2,141 | $178 |
| Ultrasonic guidance for blood vessel access | 22 | $337 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $320 | $11 |
2019: 16 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 23 | $45,375 | $1,513 |
| Short return visit (20+ min) | 127 | $15,596 | $68 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 68 | $14,475 | $193 |
| Injection of chemical agent into multiple incompetent veins of leg | 27 | $12,957 | $259 |
| New patient visit (45+ min) | 82 | $11,576 | $141 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 17 | $10,215 | $567 |
| Ultrasound of hemodialysis access | 24 | $6,160 | $137 |
| Ultrasound of leg arteries or artery grafts | 20 | $6,110 | $266 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,981 | $172 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 34 | $4,667 | $117 |
| Ultrasound of both sides of head and neck blood flow | 15 | $2,853 | $190 |
| New patient visit (30+ min) | 28 | $2,681 | $96 |
| Return visit (30+ min) | 18 | $2,456 | $102 |
| Ultrasound study of arm and leg arteries | 13 | $1,749 | $87 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 20 | $295 | $11 |
| Ultrasonic guidance for blood vessel access | 14 | $218 | $13 |
2018: 14 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 15 | $31,293 | $1,490 |
| Short return visit (20+ min) | 109 | $13,171 | $63 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 51 | $10,617 | $193 |
| New patient visit (45+ min) | 63 | $8,835 | $140 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,338 | $167 |
| Injection of chemical agent into multiple incompetent veins of leg | 13 | $5,863 | $255 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 33 | $5,302 | $118 |
| Ultrasound of hemodialysis access | 20 | $5,228 | $134 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $4,759 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,775 | $90 |
| Return visit (30+ min) | 26 | $2,995 | $97 |
| New patient visit (30+ min) | 21 | $1,784 | $85 |
| Ultrasonic guidance for blood vessel access | 29 | $456 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $265 | $11 |
2017: 15 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 19 | $35,874 | $1,708 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $10,583 | $176 |
| Short return visit (20+ min) | 83 | $10,528 | $65 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 15 | $9,783 | $575 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 42 | $8,545 | $194 |
| Ultrasound of hemodialysis access | 26 | $7,822 | $137 |
| Injection of chemical agent into multiple incompetent veins of leg | 21 | $7,806 | $230 |
| New patient visit (45+ min) | 41 | $5,989 | $146 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 34 | $5,232 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $4,670 | $90 |
| New patient visit (30+ min) | 35 | $3,125 | $89 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 11 | $2,018 | $183 |
| Return visit (30+ min) | 14 | $1,514 | $101 |
| Ultrasonic guidance for blood vessel access | 27 | $395 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $119 | $11 |
2016: 12 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 21 | $39,294 | $1,708 |
| Short return visit (20+ min) | 95 | $12,770 | $65 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 53 | $11,536 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $8,593 | $172 |
| New patient visit (45+ min) | 48 | $7,031 | $146 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 36 | $5,483 | $125 |
| New patient visit (30+ min) | 54 | $5,270 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $5,184 | $91 |
| Injection of chemical agent into multiple incompetent veins of leg | 15 | $4,595 | $230 |
| Ultrasound of hemodialysis access | 16 | $4,061 | $116 |
| Return visit (30+ min) | 19 | $2,085 | $99 |
| Ultrasonic guidance for blood vessel access | 17 | $326 | $13 |
2015: 9 services
| Short return visit (20+ min) | 67 | $8,292 | $64 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 37 | $7,845 | $196 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,960 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $5,183 | $91 |
| Injection of chemical agent into multiple incompetent veins of leg | 11 | $3,858 | $214 |
| New patient visit (30+ min) | 34 | $3,286 | $97 |
| New patient visit (45+ min) | 20 | $2,871 | $144 |
| Complete ultrasound study of arm and leg arteries | 150 | $2,679 | $18 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 18 | $2,562 | $122 |
2014: 12 services
| Relocation of arm vein with connection to arm artery for hemodialysis | 13 | $8,537 | $610 |
| Short return visit (20+ min) | 67 | $8,166 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,499 | $174 |
| Complete ultrasound study of arm and leg arteries | 236 | $4,291 | $18 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 20 | $3,908 | $186 |
| New patient visit (45+ min) | 24 | $3,547 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,873 | $90 |
| Ultrasound of hemodialysis access | 11 | $2,625 | $154 |
| New patient visit (30+ min) | 29 | $2,524 | $87 |
| Ultrasound study of arm and leg arteries | 21 | $2,271 | $87 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 14 | $1,764 | $118 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 17 | $1,705 | $100 |
2013: 10 services
| Short return visit (20+ min) | 74 | $10,955 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,088 | $165 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 21 | $4,047 | $193 |
| New patient visit (30+ min) | 40 | $3,535 | $88 |
| New patient visit (45+ min) | 23 | $3,385 | $147 |
| Complete ultrasound study of arm and leg arteries | 198 | $2,940 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,440 | $90 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 19 | $2,360 | $118 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 18 | $2,102 | $111 |
| Ultrasound study of arm and leg arteries | 15 | $1,612 | $90 |
Medicaid work
$18,964 in 2024
Medicaid paid $18,964 for 378 billed services this clinician did in 2024, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 331 | $13,913 |
| EXTREMITY STUDY | 32 | $4,206 |
| New patient visit (30+ min) | 15 | $845 |
| 2024 | 378 | 3 | 42 | $18,964 |
| 2023 | 284 | 2 | 31 | $9,429 |
| 2022 | 259 | 3 | 24 | $4,949 |
| 2021 | 306 | 3 | 26 | $4,877 |
| 2020 | 365 | 3 | 36 | $11,035 |
| 2019 | 270 | 4 | 28 | $4,717 |
| 2018 | 215 | 1 | 24 | $3,410 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 266 | $7,438 |
| Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow) | 18 | $1,991 |
2022
| Short return visit (20+ min) | 160 | $2,248 |
| Return visit (30+ min) | 69 | $1,360 |
| New patient visit (45+ min) | 30 | $1,342 |
2021
| Short return visit (20+ min) | 233 | $3,354 |
| Return visit (30+ min) | 61 | $1,207 |
| Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow) | 12 | $315 |
2020
| Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow) | 102 | $5,478 |
| Short return visit (20+ min) | 250 | $4,468 |
| LOWER EXTREMITY STUDY | 13 | $1,089 |
2019
| Short return visit (20+ min) | 230 | $3,272 |
| EXTREMITY STUDY | 14 | $543 |
| Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow) | 14 | $537 |
| New patient visit (45+ min) | 12 | $365 |
2018
| Short return visit (20+ min) | 215 | $3,410 |
Drugs they prescribed that Part D paid
$38,775
Pharmacies billed $38,775 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 12% of their Part D prescriptions (15 of 130) in 2024. Above the middle of the specialty; the typical vascular surgery clinician is at 11%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
89 generic and 41 brand-name prescriptions · $38,775 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 16 | $18,899 | $1,181 |
| Eliquis | 22 | $18,260 | $830 |
| Clopidogrel | 29 | $564 | $19 |
| Atorvastatin | 13 | $97 | $7 |
| Hydrocodone-Acetaminophen | 14 | $73 | $5 |
Year by year
| 2024 | 130 | 48 | 12% (15) | 32% | $38,775 |
| 2023 | 165 | 64 | 15% (25) | None | $32,861 |
| 2022 | 158 | 63 | 15% (23) | 20% | $25,242 |
| 2021 | 151 | 53 | 15% (23) | None | $7,038 |
| 2020 | 161 | 63 | 23% (37) | 7% | $7,303 |
| 2019 | 98 | 45 | None | None | $5,018 |
| 2018 | 114 | 48 | 11% (12) | 27% | $33,619 |
| 2017 | 88 | 37 | 17% (15) | None | $2,366 |
| 2016 | 69 | 34 | 36% (25) | None | $2,426 |
| 2015 | 60 | 34 | 27% (16) | 25% | $4,431 |
| 2014 | 65 | 31 | 32% (21) | 34% | $5,058 |
| 2013 | 43 | 25 | 30% (13) | None | $1,278 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Xarelto | 14 | $17,617 | $1,258 |
| Eliquis | 19 | $12,114 | $638 |
| Fluocinolone Acetonide | 15 | $1,032 | $69 |
| Clopidogrel | 42 | $786 | $19 |
| Hydrocodone-Acetaminophen | 24 | $120 | $5 |
2022: 4 drugs
| Xarelto | 24 | $17,784 | $741 |
| Fluocinonide | 23 | $1,606 | $70 |
| Clopidogrel | 38 | $1,059 | $28 |
| Hydrocodone-Acetaminophen | 22 | $95 | $4 |
2021: 3 drugs
| Clopidogrel | 48 | $678 | $14 |
| Gabapentin | 34 | $620 | $18 |
| Hydrocodone-Acetaminophen | 23 | $190 | $8 |
2020: 3 drugs
| Clopidogrel | 35 | $761 | $22 |
| Hydrocodone-Acetaminophen | 34 | $262 | $8 |
| Gabapentin | 35 | $209 | $6 |
2019: 3 drugs
| Fluocinonide | 13 | $563 | $43 |
| Clopidogrel | 35 | $519 | $15 |
| Gabapentin | 19 | $131 | $7 |
2018: 5 drugs
| Santyl | 15 | $24,201 | $1,613 |
| Eliquis | 12 | $5,911 | $493 |
| Fluocinonide | 16 | $688 | $43 |
| Clopidogrel | 15 | $186 | $12 |
| Gabapentin | 20 | $120 | $6 |
2017: 3 drugs
| Clopidogrel | 20 | $773 | $39 |
| Gabapentin | 14 | $103 | $7 |
| Hydrocodone-Acetaminophen | 12 | $74 | $6 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 23 | $192 | $8 |
| Gabapentin | 17 | $117 | $7 |
2015: 2 drugs
| Hydrocodone-Acetaminophen | 16 | $173 | $11 |
| Gabapentin | 12 | $52 | $4 |
2014: 2 drugs
| Lyrica | 11 | $2,243 | $204 |
| Hydrocodone-Acetaminophen | 19 | $157 | $8 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 11 | $50 | $5 |
Money from drug and device companies
$264 in 2025
| 2025 | 4 | 7 | None | $264 |
| 2024 | 6 | 9 | None | $236 |
| 2023 | 4 | 15 | None | $332 |
| 2022 | 2 | 3 | None | $71 |
| 2021 | 6 | 44 | None | $866 |
| 2020 | 6 | 10 | None | $4,622 |
| 2019 | 6 | 22 | None | $6,391 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Jetstream Sc | $149 | 3 payments
|
| Medtronic | Closurefast | $61 | 2 payments
|
| Laminate Medical Technologies | Vasq | $33 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $21 | 1 payment
|
See all 7 published payments
| Laminate Medical Technologies | Meals · 2025-06-26 | Vasq | $33 |
| Medtronic | Meals · 2025-06-09 | Hawkone | $22 |
| Boston Scientific | Meals · 2025-04-03 | Imager II | $42 |
| Boston Scientific | Meals · 2025-03-26 | Opticross 35 | $51 |
| Medtronic | Meals · 2025-03-25 | Closurefast | $40 |
| Boston Scientific | Meals · 2025-02-06 | Jetstream Sc | $57 |
| Tactile Systems Technology | Meals · 2025-01-29 | Flexitouch Plus | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $236
| Inari Medical | Flowtriever Catheter, S | $79 | 3 payments
|
| Boston Scientific | Ranger | $54 | 2 payments
|
| Medtronic | Closurefast | $46 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $21 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $20 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $16 | 1 payment
|
2023: $332
| Medtronic | In.Pact Admiral | $158 | 8 payments
|
| Boston Scientific | Comet | $74 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $54 | 3 payments
|
| AngioDynamics | Bioflo | $46 | 1 payment
|
2022: $71
| Boston Scientific | Opticross | $43 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $28 | 1 payment
|
2021: $866
| Boston Scientific | Varithena | $492 | 29 payments
|
| Medtronic | In.Pact Admiral | $181 | 7 payments
|
| Janssen Pharmaceuticals | Xarelto | $110 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $39 | 2 payments
|
| Medela | Medela Npwt Pump | $22 | 1 payment
|
| Abbott Laboratories | Femostop Femoral Cad | $22 | 1 payment
|
2020: $4,622
| AngioDynamics | Evlt | $4,253 | 1 payment
|
| Medtronic Vascular | In.Pact Admiral | $256 | 5 payments
|
| Smith+Nephew | Stravix | $50 | 1 payment
|
| Terumo Medical | Tr Band | $25 | 1 payment
|
| Boston Scientific | General - Therapies | $21 | 1 payment
|
| Pfizer | Eliquis | $17 | 1 payment
|
2019: $6,391
| AngioDynamics | Evlt | $4,800 | 1 payment
|
| Medtronic Vascular | Hawkone | $1,235 | 14 payments
|
| Boston Scientific | General Vascular Intervention | $206 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $115 | 2 payments
|
| Tactile Systems Technology | Flexitouch | $17 | 1 payment
|
| Smith+Nephew | Santyl | $17 | 1 payment
|
Professional record
- NPI
- 1033190970
- Licence
- CA A94731California A94731: Current · expires 2027-12-31
- Trained
- Indiana University School of Medicine, 1998 · 28 years ago
- Group
- West Coast Kidney · San Mateo Dialysis Associates
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2086S0129X (2086S0129X)
- Mailing address
- Po Box 590455, San Francisco, CA, 94159
- NPI first listed
- 2005-11-08
- NPI last updated
- 2019-12-17
- NPI record certified
- 2019-12-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1850 Sullivan Ave, Daly City, CA, 94015